Skip to main content
Premium Trial:

Request an Annual Quote

Genpathway s Transcription Analysis Tech Helps Baylor College Find Breast Cancer Genes

NEW YORK, May 25 (GenomeWeb News) - Researchers at Genpathway and Baylor College of Medicine have used Genpathway's transcription analysis technology to identify genes involved in breast cancer, the San Diego-based company said today.

 

The scientists used Genpathways's Factor Path assay, one of several transcription-based assays that measure transcription directly, rather than by RNA levels, to identify genes regulated by a protein overexpressed in breast cancer.

 

The assay identifies genomic DNA sequences that are functionally associated with a particular transcription factor or coregulator and quantifies the binding level of each factor across the genome. Another Genpathway assay, TranscriptionPath, showed that the genes identified are biologically relevant.

 

The study was published earlier this year in PNAS.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.